drugset / Trial / NCT00965341

Testosterone Replacement for Fatigue in Male Hypogonadic Advanced Cancer Patients

NCT00965341

Phase 3 Completed 53 enrolled M.D. Anderson Cancer Center
RandomizedSingle-groupTriple-blindTreatment

Summary

The goal of this clinical research study is to learn if and how testosterone replacement therapy may affect fatigue in males with advanced cancer and low testosterone levels.

Timeline

Start
2009-09
Primary completion
2012-09
Completion
2012-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Testosterone Small molecule 150 mg Intramuscular
Comparator Testosterone Small molecule 200 mg Intramuscular